Literature DB >> 20521024

Recombinant factor VIIa for intractable life-threatening bleeding in patients with circulatory assist devices.

Antoine G Schneider, Marie-Hélène Perez, Piergiorgio Tozzi, Pierre Voirol, Patrick Schoettker, Anne Angelillo-Scherrer, Jacques Cotting, Ludwig Von Segesser, Philippe Eggimann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20521024     DOI： 10.1007/s00134-010-1937-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery.

Authors:  Keyvan Karkouti; W Scott Beattie; Ramiro Arellano; Tim Aye; Jean S Bussieres; Jeannie L Callum; Davy Cheng; Lee Heinrich; Blaine Kent; Trevor W R Lee; Charles MacAdams; C David Mazer; Brian Muirhead; Antoine G Rochon; Fraser D Rubens; Corey Sawchuk; Shaohua Wang; Terrence Waters; Bill I Wong; Terrence M Yau
Journal:  Circulation       Date:  2008-07-07       Impact factor: 29.690

Review 2.  Guideline on antiplatelet and anticoagulation management in cardiac surgery.

Authors:  Joel Dunning; Michel Versteegh; Alessandro Fabbri; Alain Pavie; Philippe Kolh; Ulf Lockowandt; Samer A M Nashef
Journal:  Eur J Cardiothorac Surg       Date:  2008-03-28       Impact factor: 4.191

3.  rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease.

Authors:  Alex Veldman; Christoph Neuhaeuser; Hakan Akintuerk; Josef Thul; Johannes Gehron; Dietmar Schranz; Ina Michel-Behnke
Journal:  Paediatr Anaesth       Date:  2007-12       Impact factor: 2.556

4.  Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.

Authors:  Hemant S Agarwal; Jo E Bennett; Kevin B Churchwell; Karla G Christian; Davis C Drinkwater; Yi He; Mary B Taylor
Journal:  Ann Thorac Surg       Date:  2007-07       Impact factor: 4.330

5.  Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant.

Authors:  Manish J Gandhi; Richard A Pierce; Lini Zhang; Marc R Moon; George J Despotis; Nader Moazami
Journal:  J Cardiothorac Surg       Date:  2007-07-06       Impact factor: 1.637
  5 in total
  2 in total

1.  Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS).

Authors:  Claudia Heilmann; Ulrich Geisen; Friedhelm Beyersdorf; Lea Nakamura; Christoph Benk; Georg Trummer; Michael Berchtold-Herz; Christian Schlensak; Barbara Zieger
Journal:  Intensive Care Med       Date:  2011-10-01       Impact factor: 17.440

Review 2.  Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review.

Authors:  Xavier Repessé; Siu Ming Au; Nicolas Bréchot; Jean-Louis Trouillet; Pascal Leprince; Jean Chastre; Alain Combes; Charles-Edouard Luyt
Journal:  Crit Care       Date:  2013-03-25       Impact factor: 9.097
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.